|
|
|
| home > white papers > 7 Common Myths about QP Training Debunked: A Guide for Senior Managers - RSSL |
|
|
 WHITE PAPERS |
|
RSSL
|
+44 (0)118 918 4024
|
|
http://www.rssl.com
|
|
University of Reading, Whiteknights Rd, Reading, West Berkshire RG6 6LA
|
|
|
7 Common Myths about QP Training Debunked: A Guide for Senior Managers
|
|
The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
RoslinCT to Participate in the Northern Alliance Advanced Therapies Treatment Centre
RoslinCT, a UK-based cell and gene therapy contract manufacturing
organisation, is delighted to be part of the Northern Alliance Advanced
Therapies Treatment Centre (NAATTC) consortium. As an industry partner
within the consortium, RoslinCT will provide advice on the development,
manufacture and clinical supply of cell, gene and tissue engineered
therapies.
More info >> |
|
 |
White Papers |
 |
|
Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis
Aptar Pharma
Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery
with a focus on chronic rhino‑sinusitis”. This international scientific
forum was held in Paris, France on November 13th 2012. The roundtable
was organized to explore and exchange views on the science of various
forms of sinusitis and its related unmet medical needs.
More info >> |
|
 |
Industry Events |
 |
On Helix 2018
10-11 July 2018, The Cambridge Building, Babraham Research Campus
ON Helix is a two-day event aimed at informing delegates
of how to turn early stage inventions and ideas into innovative health treatments
(new medicines, novel biomarkers, useful medical devices or improved medical
practices).
More info >> |
|
|
|
